UrgentRx Closes on $2.5M in New Capital
Denver-based UrgentRx, which is developing over-the-counter flavored powder medications, recently added an additional $2.5 million in Series B funding. The funding brings the company’s total funding to date to more than $7 million. The round was led by current investors JUMP Investors and Boulevard Capital Partners. New investors include Sam Zell; David Bonderman, founder of private equity giant Texas Pacific Group; real estate magnate Herb Simon; and Academy Award-winning actress Hilary Swank.
2 April 2013•3 mins read
